Chinese Journal of Pharmaceuticals
|
2026, 57(8): 1002-1008
• Pharmaceutical Management & Information •
Patent Technology Analysis of Androgen Receptor Inhibitor Enzalutamide
Full
Hongfen MAO1, 2, Hao YU3, Taoxi LIN1, 2, Lu HUANG4, 5, 6, *
Affiliations
- 1.Sunshine Lake Pharma Co., Ltd., Dongguan 523871
- 2.State Key Lab. of Anti-infective Drug Discovery and Development, Dongguan 523871
- 3.Wuhan Zhiquan Patent Agency, Wuhan 430074
- 4.School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071
- 5.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
- 6.School of Law, Humanities and Society, Wuhan University of Technology, Wuhan 430070
Published: 2026-08-10
doi: 10.16522/j.cnki.cjph.2026.08.016
Outline
毛洪芬, 余浩, 林淘曦, 黄璐.
雄激素受体抑制剂恩扎卢胺的专利技术分析.
中国医药工业杂志,
2026
, 57
(8)
: 1002
-1008
.
DOI: 10.16522/j.cnki.cjph.2026.08.016
Hongfen MAO, Hao YU, Taoxi LIN, Lu HUANG.
Patent Technology Analysis of Androgen Receptor Inhibitor Enzalutamide[J].
Chinese Journal of Pharmaceuticals,
2026
, 57
(8)
: 1002
-1008
.
DOI: 10.16522/j.cnki.cjph.2026.08.016
Year 2026 volume 57 Issue 8
143
42
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.08.016
- Receive Date:2025-12-12
- Online Date:2026-11-05
- Published:2026-08-10